FOSAVANCE comprimés hebdomadaires 70/5600 4 pce

7680573860046 CH-57386 M05BB03 07.99.0.

Active substances:

FOSAVANCE comprimés hebdomadaires 70/5600 4 pce
FOSAVANCE comprimés hebdomadaires 70/5600 4 pce
FOSAVANCE comprimés hebdomadaires 70/5600 4 pce
1 / 3
google

Details

Product number
5738602
CPT
-
Packaging group
4
Unit
Tablette(n)
Composition
acidum alendronicum 70 mg ut natrii alendronas trihydricus, cholecalciferolum 140 µg corresp. 5600 U.I., triglycerida media, gelatina, saccharum 16 mg, amylum modificatum, E 321, aluminii silicas, lactosum 62.66 mg, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum, magnesii stearas pro compresso corresp. natrium 6.53 mg.

Articles (1)

Fosavance 70/5600, Wochentabletten
Wochentabletten
4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/01/2024
Patient information leaflet
Français
16/01/2024
Patient information leaflet
Italien
16/01/2024
Professional SmPC
Allemand
16/01/2024
Professional SmPC
Français
16/01/2024
Professional SmPC
Italien
16/01/2024

Detailed composition

Substance Quantity Type Category
acidum alendronicum
70.0 MG Substance Wirkstoff (Principe actif)
natrii alendronas trihydricus
- Substance WIZUS
cholecalciferolum
140.0 UG Substance Wirkstoff (Principe actif)
triglycerida media
- Substance HNIDK
gelatina
- Substance HNIDK
saccharum
16.0 MG Substance HBESI
amylum modificatum
- Substance HNIDK
E 321
- Substance ANTOX
aluminii silicas
- Substance HNIDK
lactosum
62.66 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
natrium
6.53 MG Substance HBESI

Authorization holder

Organon GmbH

6006 Luzern

Authorization information

Swissmedic authorization number
57386
Drug name
Fosavance, Wochentabletten
Galenic form
TAB
ATC Code
M05BB03
Authorization status
Z
Dispensation category
B
First authorization
30/11/2005
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
FOSAVANCE comprimés hebdomadaires 70/5600 4 pce
Description (DE)
FOSAVANCE Wochentabletten 70/5600 4 Stk
Market launch
28/01/2009
Narcotic (BTM)
No

Other packaging sizes

FOSAVANCE comprimés hebdomadaires 70/2800 4 pce
4 TABL
View
FOSAVANCE comprimés hebdomadaires 70/2800 12 pce
12 TABL
View
FOSAVANCE comprimés hebdomadaires 70/5600 12 pce
12 TABL
View
Buy us a coffee Explore the data